# Enhanced Molecular Microbiological Surveillance Versus Ceftriaxone Prophylaxis in Hematopoietic Cell Transplant Patients

> **NCT07308457** · NA · RECRUITING · sponsor: **Pomeranian Medical University Szczecin** · enrollment: 100 (estimated)

## Conditions studied

- Incidence of Infectious Diseases

## Interventions

- **DRUG:** Ceftriaxone 1000 MG

## Key facts

- **NCT ID:** NCT07308457
- **Lead sponsor:** Pomeranian Medical University Szczecin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-10-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07308457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07308457, "Enhanced Molecular Microbiological Surveillance Versus Ceftriaxone Prophylaxis in Hematopoietic Cell Transplant Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07308457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*